Di-2-ethylhexyl phthalate (DEHP) toxicity: organ-specific impacts and human-relevant findings in animal models & humans - review
10.23937/2572-4061.1510062 · doi-reference
The lymphatic system in the brain clearance mechanisms - new therapeuticperspectives for alzheimer’s disease
10.2174/1570159x20666220411091332 · doi-reference
The glymphatic system: a beginner’s guide
10.1007/s11064-015-1581-6 · doi-reference
Determination of phthalates in particulate matter and gaseous phase emitted into the air of the working environment
10.1007/s13762-019-02435-y · doi-reference
Toxic effects of DEHP and MEHP on gut-liver axis in rats via intestinal flora and metabolomics
10.1016/j.isci.2024.111135 · doi-reference
Secondary indoor air pollution and passive smoking associated with cannabis smoking using electric cigarette device–demonstrative in silico study
10.1371/journal.pcbi.1009004 · doi-reference
Hydrolysis of dibutyl phthalate and di(2-ethylhexyl) phthalate in human liver, small intestine, kidney, and lung: an in vitro analysis using organ subcellular fractions and recombinant carboxylesterases
10.1016/j.cbi.2023.110353 · doi-reference
In vitro intestinal and hepatic metabolism of di(2-ethylhexyl) phthalate (DEHP) in human and rat
10.1016/j.tiv.2013.03.012 · doi-reference
Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver
10.1080/10408440600779065 · doi-reference
Translocation of gold nanoparticles across the lung epithelial tissue barrier: combining in vitro and in silico methods to substitute in vivo experiments
10.1186/s12989-015-0090-8 · doi-reference
Update on macrophage clearance of inhaled micro- and nanoparticles
10.1089/jamp.2009.0797 · doi-reference
Development of nanoparticle-based mucosal drug delivery systems for controlling pharmacokinetic behaviors
10.1248/bpb.b25-00071 · doi-reference
Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery
10.1016/j.ejpb.2021.03.012 · doi-reference
Mucin biopolymers and their barrier function at airway surfaces
10.1021/acs.langmuir.0c02410 · doi-reference
Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer
10.1016/j.ejpb.2020.01.017 · doi-reference
Inhalation bioaccessibility of multi-class organic pollutants associated to atmospheric PM2.5: correlation with PM2.5 properties and health risk assessment
10.1016/j.envpol.2022.119577 · doi-reference
Inhalation bioacessibility and lung cell penetration of indoor PM2.5-bound PAEs and its implication in risk assessment
10.1016/j.envpol.2023.121216 · doi-reference
Roles of airway and intestinal epithelia in responding to pathogens and maintaining tissue homeostasis
10.3389/fcimb.2024.1346087 · doi-reference
Cilia and mucociliary clearance
10.1101/cshperspect.a028241 · doi-reference
Barrier function of airway tract epithelium
10.4161/tisb.24997 · doi-reference
Structure and function relationships of mucociliary clearance in human and rat airways
10.1038/s41467-025-57667-z · doi-reference
10.1111/j.1365-2605.2005.00607.x
10.1111/j.1365-2605.2005.00607.x · doi-reference
Diffusion of nonelectrolytes in the canine trachea: effect of tight junction
10.1152/jappl.1996.80.5.1687 · doi-reference
Physicochemical properties of mucus and their impact on transmucosal drug delivery
10.1016/j.ijpharm.2017.09.018 · doi-reference
Mechanosensitive ATP release maintains proper mucus hydration of airways
10.1126/scisignal.2003755 · doi-reference
Development of a CFD boundary condition to model transient vapor absorption in the respiratory airways
10.1115/1.4001045 · doi-reference
Transient absorption of inhaled vapors into a multilayer mucus–tissue–blood system
10.1007/s10439-009-9808-9 · doi-reference
Solubilities and surface activities of phthalates investigated by surface tension measurements
10.1002/etc.5620200113 · doi-reference
Simulation of drug transport in airway surface liquid considering mucus flow and ciliary interaction
10.1038/s41598-025-16822-8 · doi-reference
CFD-DEM study of heat transfer and particle dissolution in stirred tanks
10.1016/j.ces.2025.121858 · doi-reference
CFD-PK model for nasal suspension sprays: validation with human adult in vivo data for triamcinolone acetonide
10.1016/j.ijpharm.2024.124660 · doi-reference
Absorption and clearance of pharmaceutical aerosols in the human nose: effects of nasal spray suspension particle size and properties
10.1007/s11095-015-1837-5 · doi-reference
Absorption and clearance of pharmaceutical aerosols in the human nose: development of a CFD model
10.1089/jamp.2015.1252 · doi-reference
The rate of solution of solid substances in their own solutions
10.1021/ja02086a003 · doi-reference
Investigation of drug ciliary attachment dynamics and their impact on nanoparticle therapeutics in airway surface liquid
10.1164/ajrccm.2025.211.abstracts.a3079 · doi-reference
Nonlinear simulation of mucociliary clearance: a three- dimensional study
10.1016/j.jnnfm.2021.104727 · doi-reference
Numerical investigation of mucociliary clearance using power law and thixotropic mucus layers under discrete and continuous cilia motion
10.1007/s10237-022-01645-7 · doi-reference
Computational fluid dynamics modeling of aerosol particle transport through lung airway mucosa
10.1016/j.compchemeng.2023.108458 · doi-reference
Computational analysis of a 3D mucociliary clearance model predicting nasal drug uptake
10.1016/j.jaerosci.2021.105757 · doi-reference
Prediction of nasal spray drug absorption influenced by mucociliary clearance
10.1371/journal.pone.0246007 · doi-reference
